STOCK TITAN

Abbott Declares 399th Consecutive Quarterly Dividend

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
dividends
Rhea-AI Summary
Abbott declares quarterly dividend of 51 cents per share, marking the 399th consecutive quarterly dividend since 1924. Abbott has increased its dividend payout for 51 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index.
Positive
  • Abbott's consistent dividend payout for almost a century and its inclusion in the S&P 500 Dividend Aristocrats Index may positively impact stock price.
Negative
  • None.

ABBOTT PARK, Ill., Sept. 21, 2023 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 51 cents per share.

This marks the 399th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Nov. 15, 2023, to shareholders of record at the close of business on Oct. 13, 2023.

Abbott has increased its dividend payout for 51 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends annually for at least 25 consecutive years.

About Abbott:
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 115,000 colleagues serve people in more than 160 countries.

Connect with us at www.abbott.com, on LinkedIn at www.linkedin.com/company/abbott-/, on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews.

Cision View original content:https://www.prnewswire.com/news-releases/abbott-declares-399th-consecutive-quarterly-dividend-301935213.html

SOURCE Abbott

Abbott Laboratories

NYSE:ABT

ABT Rankings

ABT Latest News

ABT Stock Data

183.79B
1.72B
0.54%
77.02%
0.83%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
ABBOTT PARK

About ABT

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.